Can augmentation with Oxytocin be ‘too much, too soon’?

This session will discuss the key findings from the above mentioned paper. With a focus on labour augmentation with oxytocin, it will consider why the Sustainable Development Goal aiming to achieve gender equality is not incorporated into UK maternity care. This session will give an overview of the associated risks of labour augmentation with oxytocin, and contemplate how women’s rights are potentially violated through lack of informed consent, with influence from the risk discourse, changing epidemiology and sociocultural norms.

To apply for CPD after watching on-demand, please email nurseledconferences@markallengroup.com